MOTS-C is a synthetic 16-amino-acid mitochondrial-derived research peptide supplied in a 20 mg lyophilized format for controlled AMPK, metabolic-signalling, glucose-metabolism, cellular-stress, and skeletal-muscle research.
40 mg lyophilized research peptide
16-amino-acid sequence
≥98% HPLC-verified purity
Mass-spectrometry identity verification
Third-party tested
Certificate of Analysis documentation available upon request
Store at 2°C – 8°C
For laboratory research only. Not intended for human or animal consumption, administration, medical treatment, veterinary use, diagnostic use, supplement use, cosmetic use, household use, or personal use.
MOTS-C, commonly written as MOTS-c in scientific literature, is a synthetic 16-amino-acid research peptide associated with a mitochondrial-derived peptide encoded within the mitochondrial 12S rRNA region.
The name refers to Mitochondrial Open Reading Frame of the 12S rRNA type-c. Its reported amino-acid sequence is MRWQEMGYIFYPRKLR.
Research on MOTS-C has explored areas including cellular energy sensing, folate-cycle and purine-biosynthesis pathways, AMPK activation, glucose metabolism, insulin-response models, mitochondrial-to-nuclear communication, and cellular responses to metabolic stress.
Additional laboratory research has examined MOTS-C in skeletal muscle, adipose tissue, bone, exercise, and age-related physical-capacity models. Much of the research involving administered MOTS-C has been conducted in cell and animal models, while human research remains limited and has primarily examined naturally occurring MOTS-C responses.
These research findings do not establish therapeutic effectiveness, weight-management benefits, performance enhancement, lifespan extension, or suitability for personal use.
BioVault Labs offers MOTS-C in a 20 mg lyophilized research format with ≥98% HPLC-verified purity and mass-spectrometry identity verification. Products are third-party tested, with available product documentation provided upon request.
